Keratosis pilaris-like eruption secondary to nilotinib in a child.
Pediatr Dermatol
; 37(5): 968-969, 2020 Sep.
Article
in En
| MEDLINE
| ID: mdl-32602176
ABSTRACT
Nilotinib is a new multitargeted tyrosine kinase inhibitor, which is used to treat chronic myelogenous leukemia when intolerance or recurrence to imatinib occurs. We report the case of a 14-year-old patient being treated with nilotinib who developed a keratosis pilaris-like eruption. This cutaneous adverse effect is a rare but increasingly reported side effect of this therapy.
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Abnormalities, Multiple
/
Eyebrows
/
Darier Disease
Limits:
Adolescent
/
Humans
Language:
En
Year:
2020
Type:
Article